HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
Hemodynamic Frontiers in Heart Failure Registry
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years to 100 Years
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
The purpose of the HF2 (Hemodynamic Frontiers in Heart Failure) registry is to collect relevant patient-level demographic, clinical, laboratory, and hemodynamic data from patients implanted with pulmonary artery pressure sensor at participating centers to advance scientific knowledge about ambulatory hemodynamics monitoring and HF (Heart Failure) therapies. The data collected will be used for retrospective studies, quality improvement, identifying research cohorts, and member-initiated research.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Official eligibility criteria
Inclusion Criteria: 1. All patients would have been or will be implanted per indications from FDA approval/CHAMPION trial. These would be patients with NYHA (New York Heart Association) Class III heart failure who had a prior hospitalization. 2. Patients who meet the expanded FDA indication (BNP elevation without hospitalization or NYHA class II). Exclusion Criteria: 1. Patients less than 18 years of age. 2. Pregnant women at the scheduled time of PA pressure sensor implant. 3. Patients unable or unwilling to have continuity of care in the heart failure clinic.
Study sites (12)
CA
- Scripps Health · La Jolla, CA 92037Timothy Jordan, MD · Study contactThomas Heywood, MD · Principal investigatorMore trials in La Jolla
IN
- Indiana University · Bloomington, IN 47401Maya Guglin, MD · Study contactMaya Guglin, MD · Principal investigatorMore trials in Bloomington
KS
- University of Kansas Medical Center · Kansas City, KS 66160Kartik Munshi, MPH · Study contact · kmunshi@kumc.eduHirak Shah, MD · Principal investigatorMore trials in Kansas City
MN
- Fairview Health · Maplewood, MN 55109Terrie-Ann Benjamin, MD · Study contactTerrie-Ann Benjamin, MD · Principal investigatorMore trials in Maplewood
- Minneapolis Heart Institute Foundation/ Allina Health · Minneapolis, MN 55407Sarah Schwager, RN · Study contactMosi Bennett, MD · Principal investigatorMore trials in Minneapolis
MO
- Saint Luke's Health System · Kansas City, MO 64131Timothy Fendler, MD · Study contactTimothy Fendler, MD · Principal investigatorMore trials in Kansas City
NC
- University of North Carolina/ Rex Hospital, Inc. · Raleigh, NC 27607Elizabeth Volz, MD · Study contactElizabeth Volz, MS · Principal investigatorMore trials in Raleigh
OR
- Providence Heart Institute · Portland, OR 97225Christy Lenhart, RN · Study contactJacob Abraham, MD · Principal investigatorMore trials in Portland
SC
- Prisma Health · Columbia, SC 29203Suzanne Amaker · Study contactPatrick McCann, MD · Principal investigatorMore trials in Columbia
SD
- Sanford Health · Sioux Falls, SD 57104Orvaar Jonsson, MD · Study contactOrvaar Jonsson, MD · Principal investigatorMore trials in Sioux Falls
TX
- Austin Heart · Austin, TX 78756Kunjan Bhatt, MS · Study contactKunjan Bhatt, MD · Principal investigatorMore trials in Austin
- Houston Methodist DeBakey Heart and Vascular Center · Houston, TX 77030Saba Khan · Study contactAshrith Guha, MD · Principal investigatorArvind Bhimaraj, MD · Principal investigatorMore trials in Houston